Filtered By:
Drug: Botox
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 134 results found since Jan 2013.
OnabotulinumtoxinA Muscle Injection Patterns in SpasticityOnabotulinumtoxinA Muscle Injection Patterns in Spasticity
This systematic review summarizes the injection sites and dosing patterns of Botox injections for adult spasticity due to a variety of causes such as MS, stroke, or brain or cord injury. BMC Neurology
Source: Medscape Today Headlines - November 13, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
How Botox can help stroke victims: Anti-wrinkle treatment allows paralysed limbs to function better
When injected into the ankle, it eases painful muscle spasms and allows the foot to function more normally.
Source: the Mail online | Health - February 22, 2014 Category: Consumer Health News Source Type: news
The latest lifeline for patients paralysed by strokes... Botox: Anti-wrinkle jab can help restore lost movement
Lesley Berry, 27, from Walsall, developed dystonia after a stroke and it was only when she started receiving Botox jabs that she bounced back.
Source: the Mail online | Health - March 8, 2014 Category: Consumer Health News Source Type: news
Response to IncobotulinumtoxinA After Resistance to OnabotulinumtoxinA and RimabotulinumtoxinB (P7.061)
CONCLUSIONS:Switching to incobotulinumtoxinA after secondary resistance to onabotulinumtoxinA and rimabotulinumtoxinB may be a viable treatment option in dystonia.Study Supported by:National Institutes of Health- National Institutes of Neurological Diseases and Stroke and the Dystonia Medical Research FoundationDisclosure: Dr. Ramos has received personal compensation for activities with the National Inistitutes of Health as an employee, and the Dystonia Medical Research Foundation. Dr. Karp has nothing to disclose. Dr. Lungu has nothing to disclose. Dr. Alter has nothing to disclose. Dr. Hallett has received personal compe...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Ramos, V., Karp, B., Lungu, C., Alter, K., Hallett, M. Tags: Movement Disorders: Dystonia Treatment Source Type: research
Top medicine articles for April 2014
A collection of some interesting medical articles published recently:A Big Bet on Gluten-Free: 11% of households reporting purchases of gluten-free foods in 2013 (doubled in 3 yrs). 30% of the public says it would like to cut back on the amount of gluten it’s eating. "There is a growing population of people who have somehow heard that gluten-free is healthier or think of it as fashionable, and when they remove gluten from their diet, they’re inadvertently taking out a lot of processed foods and are really feeling the benefits of eating healthier foods.” http://buff.ly/1mt9phmNew nomenclature and classifications are p...
Source: Clinical Cases and Images - April 23, 2014 Category: Journals (General) Tags: Health News of the Day Source Type: news
Sensitivity of the NeuroFlexor method to measure change in spasticity after treatment with botulinum toxin A in wrist and finger muscles.
Conclusion: At the group level, the sensitivity of NeuroFlexor is good enough to detect reduction in spasticity after treatment with BoNT-A. Further work is needed to establish the sensitivity of NeuroFlexor on an individual level.
PMID: 24850135 [PubMed - in process]
Source: Journal of Rehabilitation Medicine - November 14, 2014 Category: Rehabilitation Tags: J Rehabil Med Source Type: research
FDA Approves Botox for Lower Limb Spasticity FDA Approves Botox for Lower Limb Spasticity
The FDA has approved a new indication for Allergan's Botox (onabotulinumtoxinA): lower limb spasticity seen after stroke and in other neurologic disorders. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - January 26, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
Assessing the immediate impact of botulinum toxin injection on impedance of spastic muscle
Since the 1980s, Botulinum toxin type A (BoNT-A) has been widely used in the management of spasticity caused by stroke, spinal cord injury, or cerebral palsy [1 –5]. The underlying mechanisms of BoNT-A is that it can effectively block the release of acetylcholine from the nerve endings, thus producing a progressive paralysis of the muscle [1,6]. Subsequent to the intramuscular BoNT-A injection, alterations in the physiological and mechanical properties of muscle have been reported in histological, mechanical, and medical imaging studies [7–11].
Source: Medical Engineering and Physics - February 3, 2017 Category: Biomedical Engineering Authors: Xiaoyan Li, Henry Shin, Le Li, Elaine Magat, Sheng Li, Ping Zhou Tags: Technical note Source Type: research
Outcomes of Botulinum Toxin Type A for equinovarus deformity in patients with CVA: A case series.
CONCLUSION: Although BTX-A injections improved spasticity, this improvement did not translate to gait outcomes. Addition of physical therapy interventions appeared to improve gait outcomes in this case series. We suggest future randomized control studies to compare effects of physical therapy alone to BTX-A combined with physical therapy on gait outcomes.
PMID: 28481738 [PubMed - as supplied by publisher]
Source: Physiotherapy Theory and Practice - May 8, 2017 Category: Physiotherapy Authors: Karakkattil P, Trudelle-Jackson E, Brown HH, Hammontree P, Okolo M Tags: Physiother Theory Pract Source Type: research
Detection of Botulinum Toxin Muscle Effect in Humans Using Magnetic Resonance Imaging: A Qualitative Case Series
Conclusions This descriptive case series is among the first attempts to quantify BTME within human muscle. Our findings are preliminary and are limited by a few inconsistencies. However, we conclude that use of magnetic resonance imaging to detect the volume of BTME is feasible and may assist researchers in modeling the spread and diffusion of BT within human muscle. Level of Evidence To be determined.
Source: PMandR - May 31, 2017 Category: Rehabilitation Source Type: research
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity
AbstractSpasticity with muscle paresis and loss of dexterity is a common feature of upper motor neuron syndrome due to injuries or the pyramidal tract in several neurological conditions. Botulinum toxin type A has been considered the gold standard treatment for spasticity and movement disorders, with efficacy, reversibility, and low prevalence of complications. During the last 30 years, thousands of studies of its use have been performed, but few guidelines are available. Therefore, there is great variability in both the doses and intervals of administration and the approaches taken by clinicians with considerable experi...
Source: Drugs - July 19, 2017 Category: Drugs & Pharmacology Source Type: research
Poster 307: Non-Rhythmic Recurrent Shaking After Right Basal Ganglia Stroke: A Case Report
Aaron Hanyu-Deutmeyer: My spouse/partner has a relationship with Allergan Speakers bureau, My spouse/partner has a relationship with Allergan provided Botox for injection
Source: PM and R - September 1, 2017 Category: Rehabilitation Authors: Aaron A. Hanyu-Deutmeyer, Padma K. Srigiriraju Source Type: research
A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK.
CONCLUSIONS: Current UK practice of Botulinum Toxin type A injections for hemiplegic shoulder pain associated with spasticity is highly variable. There are large gaps between current practice and available evidence with regards to muscle selection and doses used. A number of areas for further investigation have been identified to progress current understanding of this intervention. Implications for rehabilitation There are wide variations in practice for this complex intervention and clinicians should consider that their individual decision-making could be based on their own beliefs rather than available evidence. Pectoral...
Source: Disability and Rehabilitation - November 10, 2017 Category: Rehabilitation Authors: Holmes RJ, Connell LA Tags: Disabil Rehabil Source Type: research
Teamwork and toughness: Living with cerebral palsy
Growing up in Querétaro, Mexico, María was an exceptionally bright and inquisitive child. At just 18 months old, she spoke at the level of a 6-year-old, and could even sing the tongue-twisting “Supercalifragilisticexpialidocious” song. Her parents marveled at her intelligence at such a young age, but there was something in her development that seemed off.
“At 1 year, she wasn’t crawling well and had difficulty standing,” her mother, María José, recalls. “She hadn’t learned to walk by 18 months, and she would crawl by pulling her two legs at the same time — like a little bunny.” Her parents knew that s...
Source: Thrive, Children's Hospital Boston - February 2, 2018 Category: Pediatrics Authors: Connor Ertz Tags: Our Patients’ Stories cerebral palsy Cerebral Palsy Center Child and Young Adult Hip Preservation Program Dr. Benjamin Shore Dr. Donna Nimec Source Type: news
Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: A case report
Single case report.
Source: Journal of Hand Therapy - July 16, 2018 Category: Rehabilitation Authors: Yuichi Hirakawa, Soichiro Koyama, Shigeo Tanabe, Kazuya Takeda, Tetsuya Ueda, Ikuo Motoya, Hiroaki Sakurai, Yoshikiyo Kanada, Nobutoshi Kawamura, Mami Kawamura, Junji Nagata, Tetsuo Kanno Tags: Case Report Source Type: research
